Cancer treatment and cognitive function: Chemotherapy is not the only culprit

ONCOLOGY (United States)

Volumn 28, Issue 9, 2014, Pages

  Ganz, Patricia A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLOPHOSPHAMIDE; CYTOKINE; DOXORUBICIN; ESTROGEN; FLUOROURACIL; METHOTREXATE; REACTIVE OXYGEN METABOLITE; TESTOSTERONE; TUMOR NECROSIS FACTOR RECEPTOR 2;

ARTICLE; BLOOD BRAIN BARRIER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER THERAPY; COGNITION; COGNITIVE DEFECT; DNA DAMAGE; ELECTROENCEPHALOGRAM; GENETIC PREDISPOSITION; INFLAMMATION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; TELOMERE SHORTENING;

EID: 84907236007     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. de Moor JS, Mariotto AB, Parry C, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomark Prev. 2013;22:561-70.
2. Moore HCF. An overview of chemotherapy-related cognitive dysfunction, or ‘chemobrain.’ Oncology (Williston Park). 2014;28:797-804.
3. Ganz PA.“ Doctor, will the treatment you are recommending cause chemobrain?” J Clin Oncol. 2012;30:229-31.
4. Pomykala KL, de Ruiter MB, Deprez S et al. Integrating imaging findings in evaluating the post-chemotherapy brain. Brain Imaging Behav. 2013;7:436-52.
5. Deprez S, Vandenbulcke M, Peeters R, et al. Longitudinal assessment of chemotherapy-induced alterations in brain activation during multitasking and its relation with cognitive complaints. J Clin Oncol. 2014;32:2031-8.
6. Schagen SB, Muller MJ, Boogerd W, et al. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol. 2002;13:1387.
7. Schagen SB, van Dam FS, Muller MJ, et al. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer. 1999;85:640-50.
8. Seigers R, Schagen SB, Van TO, Dietrich J. Chemotherapy-related cognitive dysfunction: current animal studies and future directions. Brain Imaging Behav. 2013;7:453-9.
9. Ahles TA. Brain vulnerability to chemotherapy toxicities. Psycho-Oncology. 2012;21:1141-8.
10. Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer. 2007;7:192-201.
11. Ganz PA, Bower JE, Kwan L, et al. Does tumor necrosis factor-alpha (TNFalpha) play a role in post-chemotherapy cerebral dysfunction? Brain, Behavior, and Immunity. 2013;30, Supplement:S99-S108.
12. Joshi G, Sultana R, Tangpong J, et al. Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain. Free Radical Res. 2005;39:1147-54.
13. Ganz PA, Petersen L, Castellon SA, et al. Cognitive function after the initiation of adjuvant endocrine therapy in early stage breast cancer: an observational cohort study. J Clin Oncol. 2014. In press.
14. Hedayati E, Schedin A, Nyman H, et al. The effects of breast cancer diagnosis and surgery on cognitive functions. Acta Oncologica. 2011;50:1027-36.
15. Hedayati E, Alinaghizadeh H, Schedin A, et al. Effects of adjuvant treatment on cognitive function in women with early breast cancer. Eur J Oncol Nurs. 2012;16:315-22.
16. Bower JE, Ganz PA, Irwin MR, et al. Cytokine genetic variations and fatigue among patients with breast cancer. J Clin Oncol. 2013;31:1656-61.
17. Von Ah D, Carpenter JS, Saykin A, et al. Advanced cognitive training for breast cancer survivors: a randomized controlled trial. Breast Cancer Res Treat. 2012;135:799-809.
18. Kesler S, Hadi Hosseini SM, Heckler C, et al. Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors. Clin Breast Cancer. 2013;13:299-306.
19. Ercoli LM, Castellon SA, Hunter AM, et al. Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints. Brain Imaging Behav. 2013;7:543-53.
20. Schuurs A, Green HJ. A feasibility study of group cognitive rehabilitation for cancer survivors: enhancing cognitive function and quality of life. Psycho-Oncology. 2013;22:1043-9.
21. Cherrier MM, Anderson K, David D, et al. A randomized trial of cognitive rehabilitation in cancer survivors. Life Sci. 2013;93:617-22.
22. Ercoli L, Castellon S, Hunter A, et al. Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints. Brain Imag Behav. 2013:1-11.
23. Hunter AM, Kwan L, Ercoli LM, et al. Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study. Psycho-Oncology. 2014;23:713-5.
24. Ercoli LM, Castellon S, Petersen L, et al. Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial. International Cancer and Cognition Task Force Meeting; Seattle, WA 2014.
25. Moore HF, Parsons M, Yue G, et al. Electroencephalogram power changes as a correlate of chemotherapy-associated fatigue and cognitive dysfunction. Support Care Cancer. 2014;22:2127-31.
26. Anguera JA, Boccanfuso J, Rintoul JL, et al. Video game training enhances cognitive control in older adults. Nature. [Letter]. 2013;501:97-101.